Skip to main content
INBX logo
INBX
(NASDAQ)
Inhibrx Biosciences, Inc.
$110.01-- (--)
Loading... - Market loading

Inhibrx Biosciences (INBX) Stock Price & Financial Analysis

Inhibrx Biosciences Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$104.42 - $113.95
52-Week High$155.29
52-Week Low$10.84
Open$110.98
Volume428.16K
Average Volume (3M)583.77K
Market Cap1.64B
Shares Outstanding15.49M
Price to Sales (P/S)1294.24
Price to Book (P/B)210.50
EV/EBITDA-13.12
Revenue (TTM)1.30M
Net Income (TTM)-140.06M
Free Cash Flow (TTM)-129.82M
EPS (TTM)$-9.05
Profit Margin-10773.46%
Operating Margin-10386.54%
Return on Equity (ROE)-1752.22%
Debt to Equity12.87
50-Day MA$87.63
200-Day MA$65.20
52-Week Change989.50%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateMay 30, 2024

Frequently Asked Questions About Inhibrx Biosciences

What is the current stock price for INBX?

As of the latest trading session, INBX stock trades at $110.01. The 52-week range is $10.84–$155.29, with a day range of $104.42–$113.95.

What is the P/E ratio for INBX?

The P/E ratio (Price-to-Earnings) for INBX is shown in the Key Statistics section. This valuation metric helps compare Inhibrx Biosciences, Inc. to industry peers.

Does INBX pay dividends?

Inhibrx Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for INBX?

Based on 1 analyst, the consensus for INBX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of INBX?

Inhibrx Biosciences's market capitalization is $1.70B, classifying it as a small-cap company. Inhibrx Biosciences operates in the Healthcare sector within the Biotechnology industry.